Pfizer to Invest $120 Million to Produce COVID-19 Oral Treatment in the U.S.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Stay updated with breaking news from Medication Errors. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Business Wire. The AP news staff was not involved in its creation.
There have been several incidents of hospital staffers searching computerized medication cabinets with three or fewer letters and then administering or nearly administering the wrong drug. Hospitals are not required to report most drug mix-ups.
/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented new research from its psychiatry portfolio at the 2022 Congress of the Schizophrenia International...
- Detailed Results Presented From ENLIGHTEN-Early Phase 3b Study of LYBALVI in Patients Early in Illness - DUBLIN, April 7, 2022 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today presented
22.03.2022 - Pfizer Inc. (NYSE: PFE) announced today an agreement with UNICEF to supply up to 4 million treatment courses of its COVID-19 oral treatment, PAXLOVID (nirmatrelvir [PF-07321332] tablets and ritonavir tablets), to 95 low- and middle-income countries, ...